Neurogenetic determinism and the new euphenics

BMJ

Volumn 318, Issue 7196, 1999, Pages 1488-

  Craddock, Nick ^a   Jones, Ian R ^a   Kent, Lindsey ^a   Williams, Justin H G ^b   Rose, Steven ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b Centre for Child Health   (United Kingdom)

^c OPEN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; ETHICS; HUMAN; LETTER; MEDICAL GENETICS; MENTAL DISEASE; NEUROPSYCHIATRY; PRESCRIPTION; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY; WELLBEING;

EID: 0033614625     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7196.1488     Document Type: Letter

References (7)

1. Rose SPR. BMJ 1998; 317: 1707–1708. (19-26 December.)
2. Craddock N, Owen MJ. Modern molecular genetic approaches to psychiatric disease. Br Med Bull 1996; 52: 434–452.
3. Jones I, Craddock N. The crisis in psychiatry. Lancet 1997; 349: 1550.
4. Jones I, Craddock N. Ethical issues in genetics of mental disorders. Lancet 1998; 352: 1778.
5. Swanson JM, Sergeant JA, Taylor E, Sonuga-Barker EJS, Jensen PS, Cantwell DP. Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998; 351: 429–433.
6. Rose SPR. (1998). Neurogenetic determinism and the new euphenics. BMJ 1998; 317: 1707–1708. (19-26 December.)
7. Rose S. Lifelines—biology, freedom, determinism. London: Penguin, 1997.